JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 53(2019) N 2 p. 212-226; DOI 10.1134/S0026893319020171 Full Text

A.A. Zotova1,2*, A.A. Atemasova1, A.V. Filatov3, D.V. Mazurov2,3

HIV Restriction Factors and Their Ambiguous Role during Infection

1Moscow State University, Faculty of Biology, Moscow, 119991 Russia
2Cell and Gene Technology Group, Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334 Russia
3National Research Center-Institute of Immunology of Federal Medical-Biological Agency of Russia, Moscow, 115478 Russia

*ashunaeva@gmail.com
Received - 2018-11-02; Revised - 2018-11-18; Accepted - 2018-11-18

Currently, more than 37 million individuals worldwide are infected with the human immunodeficiency virus (HIV). Antiretroviral therapy may control the viral infection but is incapable of eradicating it. It is important to understand how cells respond to HIV-1 infection and what cellular factors are involved in this process to develop novel classes of antiviral drugs. This review summarizes the current understanding of the HIV restriction mechanism. We discuss the ambiguous role of HIV restriction factors in viral infection and counteraction mediated by HIV-1 accessory proteins.

HIV, restriction factors, ISGs, HIV accessory proteins



JMB-FOOTER RAS-JOURNALS